###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
###end article-title 0
###begin p 1
Conceived and designed the experiments: LMM CEL DEA CS LSW JAT DAH. Performed the experiments: LMM CEL KD CS PMC CA. Analyzed the data: LMM CEL JC KD DEA CS BH NW. Contributed reagents/materials/analysis tools: LMM CEL JC JRO SLH AC SS TI PLDJ LSW JAT DAH. Wrote the paper: LMM CEL JC KD DEA LSW JAT DAH.
###end p 1
###begin p 2
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 184 189 <span type="species:ncbi:9606">Human</span>
###xml 824 829 <span type="species:ncbi:9606">child</span>
Multiple sclerosis (MS) and type 1 diabetes (T1D) are organ-specific autoimmune disorders with significant heritability, part of which is conferred by shared alleles. For decades, the Human Leukocyte Antigen (HLA) complex was the only known susceptibility locus for both T1D and MS, but loci outside the HLA complex harboring risk alleles have been discovered and fully replicated. A genome-wide association scan for MS risk genes and candidate gene association studies have previously described the IL2RA gene region as a shared autoimmune locus. In order to investigate whether autoimmunity risk at IL2RA was due to distinct or shared alleles, we performed a genetic association study of three IL2RA variants in a DNA collection of up to 9,407 healthy controls, 2,420 MS, and 6,425 T1D subjects as well as 1,303 MS parent/child trios. Here, we report "allelic heterogeneity" at the IL2RA region between MS and T1D. We observe an allele associated with susceptibility to one disease and risk to the other, an allele that confers susceptibility to both diseases, and an allele that may only confer susceptibility to T1D. In addition, we tested the levels of soluble interleukin-2 receptor (sIL-2RA) in the serum from up to 69 healthy control subjects, 285 MS, and 1,317 T1D subjects. We demonstrate that multiple variants independently correlate with sIL-2RA levels.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 341 346 <span type="species:ncbi:9606">Human</span>
###xml 456 461 <span type="species:ncbi:9606">human</span>
Multiple sclerosis (MS) and type 1 diabetes (T1D) are common, organ-specific inflammatory disorders that continue to increase in global prevalence. The processes leading to both T1D and MS are genetically determined and are thought to involve an autoimmune mechanism. After decades of research into the genetic basis of both MS and T1D, the Human Leukocyte Antigen Complex was the only known susceptibility locus for both T1D and MS. The sequencing of the human genome followed by the generation of the haplotype map, a catalogue of common genetic variation, has allowed the elucidation of allelic variants that define disease risk. Our groups have performed genome-wide association scans and candidate gene studies in both T1D and MS; the final results have identified loci outside the HLA harboring fully replicated risk alleles. Here, we show that the IL-2RA gene encoding a critical regulator of immune responses, the alpha chain of the interleukin-2 receptor, harbors variants that differentially confer risk to MS and T1D. In addition, several independent variants correlate with levels of soluble interleukin-2 receptor in the serum. This finding has critical implications for the field of complex disease genetics as it emphasizes the caution that must be taken when interpreting results for such a complex region with multiple susceptibility alleles.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Maier1">[1]</xref>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 271 274 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Vang1">[2]</xref>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STAT4</italic>
###xml 310 313 310 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Remmers1">[3]</xref>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7R</italic>
###xml 332 340 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0350</italic>
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Gregory1">[4]</xref>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 442 445 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Vella1">[7]</xref>
###xml 446 449 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Qu1">[9]</xref>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Matesanz1">[10]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Brand1">[11]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Harley1">[12]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Wellcome1">[13]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Barton1">[14]</xref>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Recent genome wide association (GWA) and candidate gene studies across human autoimmune disease revealed a shared genetic architecture [1]. These include PTPN22, associated with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), T1D, and Graves' Disease (GD) [2], STAT4, associated with SLE and RA [3], and the IL7R and KIAA0350 gene regions, which are shared between T1D and MS [4]-[6]. The IL2RA gene region is shared among T1D [7]-[9], MS [6],[10], GD [11], SLE [12] and RA [13],[14]. This overlap of risk loci among autoimmune diseases raises the possibilities that either (1) the same alleles, (2) non-shared, disease-specific alleles, or perhaps (3) a combination of shared and disease-specific alleles confer risk to each of the individual diseases.
###end p 6
###begin p 7
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 418 419 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 429 431 429 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 481 482 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 492 494 492 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 575 578 575 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 694 695 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 819 820 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 889 893 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The2">[15]</xref>
###xml 1113 1118 1113 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 1192 1193 1192 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1203 1206 1203 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 1257 1258 1257 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1268 1270 1268 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 1315 1316 1315 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1326 1329 1326 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;23</sup>
###xml 1512 1516 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The2">[15]</xref>
In the IL-2RA gene region, a GWA study for MS risk alleles and a large-scale fine-mapping study in T1D provided compelling evidence for a shared autoimmunity locus. A GWA study for MS susceptibility genes performed by The International Multiple Sclerosis Genetics Consortium [6] highlighted two SNPs in the IL-2RA gene: rs12722489 (Odds Ratio (OR) for minor allele  = 0.80; 95% confidence interval (c.i.) = 0.74-0.86, P = 2.96x10-8) and rs2104286 (OR = 0.84; 95% c.i. = 0.79-0.90; P = 2.16x10-7). These are in moderate linkage disequilibrium (LD) with each other (r2 = 0.62; [6]). The MS association at IL2RA has recently been replicated in over 600 multiplex families from Canada (rs12722489, P = 0.009; OR = 0.81; 95% c.i. = 0.70-0.93) and 1,146 subjects with MS and 1,309 healthy controls from Australia (rs2104286, P = 0.033; OR = 0.86; 95% c.i. = 0.75-0.99). In an extension analysis [15] using data from 12,360 subjects previously reported and new data from 11,019 unrelated MS subjects, 13,616 controls and 2,811 trio families (8,433 individuals) from across Europe, the association for MS risk at the two IL2RA variants became unequivocal (rs12722489, OR = 0.81 (95% c.i. 0.77-0.85), P = 2.24x10-15; relative risk, RR,  = 0.81 (95% c.i. 0.72-0.91), P = 5.47x10-4; rs2104286, OR = 0.80 (95% c.i. 0.77-0.84), P = 2.38x10-23; RR = 0.78 (95% c.i. 0.71-0.86)). Furthermore, this study demonstrated that rs2104286 is the primary association, and thus accounts for the association signal observed at rs12722489 [15].
###end p 7
###begin p 8
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBM17</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 373 376 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 662 665 662 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
For T1D susceptibility, two associations are known to exist at IL2RA. In a large-scale fine-mapping study of over 300 SNPs in the IL2RA-RBM17 region in our T1D collection, we localized the association to T1D susceptibility to two groups of SNPs located in the 5' region and intron 1 of IL2RA; any one or more SNPs from each group could potentially be the causal variant(s) [8]. The minor alleles at rs41295061 and rs11594656 were found to confer protection to T1D in a case-control DNA collection of 5,312 T1D subjects and 6,855 controls (rs41295061, OR,  = 0.65, rs11594656, OR = 0.87) and 2,612 families with T1D (rs41295061, RR = 0.70, rs11594656, RR = 0.89) [8].
###end p 8
###begin p 9
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Malek1">[16]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Kim1">[17]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Adachi1">[22]</xref>
###xml 449 452 449 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
The IL-2/IL-2RA(CD25) pathway plays an essential role in regulating immune responses [16]. IL-2 is central for both expansion and apoptosis of T cells, while high concentrations of soluble IL-2RA (sIL-2RA) are found in sera from healthy subjects and are increased in subjects with autoimmune disease, inflammation and infection [17]-[22]. Interestingly, we have previously shown that T1D-associated variants correlate with reduced levels of sIL-2RA [8].
###end p 9
###begin p 10
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 636 639 636 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 1053 1058 <span type="species:ncbi:9606">human</span>
Our knowledge of the IL-2R pathway and its central role in regulating immune responses prompted us to examine whether disease susceptibility at IL2RA to T1D and MS is due to shared or distinct genetic variants. First, we demonstrate extensive allelic heterogeneity between T1D and MS, including an allelic variant that is associated with susceptibility to one autoimmune disease but protection to the other. By extending previous genotype/phenotype correlations at IL2RA, we provide insight into both common and distinct functional mechanisms. Second, we extend our findings on the correlation between sIL-2RA levels and IL2RA genotype [8]. Using regression analyses, we show that sIL-2RA levels are determined by independent groups of SNPs, similar to what we show for disease susceptibility. Taken together, we demonstrate heterogeneity in the production of sIL-2RA in association with the genetic heterogeneity reported here. The approach described in this work will be instrumental for future investigations of complex causal mechanisms involved in human disease.
###end p 10
###begin title 11
Results/Discussion
###end title 11
###begin p 12
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 93 96 93 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The2">[15]</xref>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Weber1">[23]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Ramagopalan1">[24]</xref>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 237 239 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 242 249 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t001">Table 1</xref>
###xml 251 259 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000322-g001">Figure 1</xref>
###xml 261 270 261 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s002">Tables S1</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s003">S2</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s004">S3</xref>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 320 323 320 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 660 661 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 670 677 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t001">Table 1</xref>
###xml 937 945 937 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s005">Table S4</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s006">S5</xref>
###xml 845 850 <span type="species:ncbi:9606">child</span>
The most associated IL2RA SNP for MS susceptibility is rs2104286 located in intron 1 of IL2RA[6],[15],[23],[24]. In the MS case-control and family collections we have analyzed, rs2104286 has an OR of 0.85 (95% c.i. 0.79-0.92, P = 6.27x10-7) (Table 1, Figure 1, Tables S1, S2, and S3). For T1D susceptibility, Lowe et al.[8] reported independent associations with two groups of indistinguishable SNPs, marked by rs41295061 ('Group I') and rs11594656 ('Group II') located in the 5' region of the IL2RA gene. Here, we test these two SNPs for MS susceptibility. Single locus tests show no evidence of association between MS susceptibility and Group I (rs41295061; P = 0.10, Table 1). We note that assuming an effect size of rs41295061 as observed for T1D susceptibility (OR in the order of 0.6), the power to detect this effect is 97% in the parent/child trios and 100% in the MS case-control collection, given a significance level of 0.05 (Table S4, S5).
###end p 12
###begin title 13
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
Association of IL2RA SNPs with multiple sclerosis and type 1 diabetes.
###end title 13
###begin p 14
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 292 293 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
(A) Linkage disequilibrium (r2 values) between the SNPs in this study. r2 values are based on 6,317 control subjects from Great Britain. (B) Disease associations (Odds Ratios of minor allele) with MS and T1D are shown for the three SNPs in this study. (C) The SNPs that are perfect proxies (r2 = 1) for the SNPs studied are shown. These perfect proxy SNPs are based on the analysis of 32 CEPH individuals. MS, multiple sclerosis. T1D, type 1 diabetes.
###end p 14
###begin title 15
###xml 129 134 <span type="species:ncbi:9606">child</span>
Single locus analysis of the two MS-associated SNPs and the two T1D-associated SNPs in a DNA collection of up to 1,303 MS parent-child trios with MS from the USA, 2,440 MS cases from the USA, 6,425 T1D cases from GB and 9,407 healthy controls from the USA and GB.
###end title 15
###begin p 16
###xml 158 161 158 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 290 293 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 578 580 578 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 592 593 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 807 808 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 818 820 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
Note that for rs2104286 and rs41295061 in the MS collection, we included previously published genotyping data (USA trios, US MS cases, US controls, GB cases; [6]). For rs41295061 and rs11594656 in the T1D collection, we included previously published genotyping data (GB cases and controls; [8]. We assumed a model of multiplicative effects when it was not significantly different from the full genotype model (P>0.05). For rs2104286, we used the full genotype model in the USA case-control collection, as it was significantly different from the multiplicative model (P = 6.57x10-3). Combined P values for the USA and GB case-control were stratified by population (note that for population stratification, a 2-df test was used for rs2104286 as there was a significant difference between 1-df and 2-df tests, P = 3.85x10-3). T, transmitted; NT, not transmitted; MAF, minor allele frequency in unaffected parents or control subjects; RR, relative risk of minor allele; OR, odds ratio of minor allele; 95% c.i. = 95% confidence interval.
###end p 16
###begin p 17
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 72 79 72 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t001">Table 1</xref>
###xml 81 89 81 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000322-g001">Figure 1</xref>
###xml 229 236 229 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t001">Table 1</xref>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 449 457 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s007">Table S6</xref>
###xml 311 316 <span type="species:ncbi:9606">child</span>
Furthermore, Group II is associated with MS (rs11594656; P = 7.67x10-4 (Table 1, Figure 1). Surprisingly, at rs11594656, the minor allele A is associated with protection from T1D (OR = 0.87), but susceptibility to MS (OR = 1.17, Table 1) in the MS case-control collection. The lack of association in the parent/child trio collection may be due to low statistical power, which is only 31% for a variant with OR = 1.1 for this sample size and P<0.05 (Table S6).
###end p 17
###begin p 18
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s008">Table S7</xref>
###xml 469 477 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s009">Table S8</xref>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
The lack of MS association to Group I SNPs and the opposing effects associated with Group II SNPs indicates the presence of allelic heterogeneity between T1D and MS at Group I and Group II SNPs. In addition, we note that the MS-association observed at rs11594656 presents an independent MS-association from rs2104286 (Table S7). Taken together, rs2104286 marks an independent association from Group II SNPs (marked by rs11594656); we term this association 'Group III'. Table S8 shows all IL2RA region SNPs in LD with rs2104286.
###end p 18
###begin p 19
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;25</sup>
###xml 360 367 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t001">Table 1</xref>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 525 528 525 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 530 538 530 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s010">Table S9</xref>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 621 624 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;13</sup>
###xml 626 633 626 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t001">Table 1</xref>
###xml 745 746 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 756 758 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 760 769 760 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s011">Table S10</xref>
###xml 963 970 963 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t001">Table 1</xref>
###xml 972 980 972 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000322-g001">Figure 1</xref>
###xml 1066 1071 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
In order to explore the association of Group III SNPs to T1D susceptibility, we performed forward logistic regression analysis of the Group I, II and III SNPs in 6,425 T1D cases and 6,862 controls with complete genotyping data. The results are consistent with our previous study [8]: Group I has the strongest association with T1D (rs41295061, P = 6.43x10-25; Table 1). The first selected SNP in the regression analysis is rs41295061 and the second SNP to be added to the model including rs41295061 is rs11594656 (P = 2.07x10-10, Table S9). Interestingly, Group III also shows association with T1D (rs2104686, P = 1.27x10-13, Table 1). When we add rs2104286 to the model that includes both rs41295061 and rs11594656, this SNP adds to the model (P = 1.30x10-5; Table S10). These data indicate that rs2104286 (marking Group III) is independently associated with T1D. At rs2104286, it is the minor allele G of rs2104286 that confers protection from both MS and T1D (Table 1, Figure 1). We note here that the major allele at all T1D-associated loci discovered so far at IL2RA encodes the susceptibility allele.
###end p 19
###begin p 20
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 253 259 253 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 259 262 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Kim1">[17]</xref>
###xml 988 995 988 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t002">Table 2</xref>
###xml 997 1007 997 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s012">Tables S11</xref>
###xml 1009 1012 1009 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s013">S12</xref>
###xml 1639 1644 1639 1644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 1803 1810 1803 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000322-t002">Table 2</xref>
###xml 1845 1855 1845 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s015">Tables S14</xref>
###xml 1857 1860 1857 1860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s016">S15</xref>
Defining the heterogeneous genetic basis at IL2RA is critical for the success of functional studies aiming to connect the risk alleles with immunophenotypes and autoimmune mechanisms controlled by this locus. In a collection of T1D plasma samples, Lowe et al.[8] reported a correlation between the T1D IL2RA susceptibility alleles and decreased levels of sIL-2RA. This raised the possibility of a link between T1D susceptibility and the levels of this biomarker of peripheral inflammation [17]. Here, we investigate the correlation of sIL-2RA and the newly identified Group III SNPs, marked by rs2104286, which associates with both MS and T1D. In a replication study of up to 69 healthy control samples and 285 MS case samples we first confirm the previously observed correlation between rs11594656 with sIL-2RA levels; however, the low minor allele frequency of rs41295061 results in statistical power that was too low to detect the association with sIL-2RA in these sample collections (Table 2; Tables S11, S12). Most interestingly, however, an additional correlation between genotype and sIL-2RA level is observed at rs2104286 in our healthy control, MS and T1D collections, where the minor allele associates with decreased sIL-2RA levels. Given that the minor allele at rs2104286 associates with protection from both MS and T1D, this finding is unexpected because decreased sIL-2RA levels correlate with T1D susceptibility alleles at rs41295061 and rs11594656. This led us to investigate whether the three SNPs were marking independent associations with sIL-2RA levels, similarly to what we have observed for disease susceptibility at IL2RA. Indeed, using regression analyses in the T1D case collection, we show that the associations between sIL-2RA levels and rs11594656, rs41295061 and rs2104286 (Table 2) are independent from each other (Tables S14, S15).
###end p 20
###begin title 21
sIL-2RA concentrations in the sera of healthy controls and MS cases and plasma samples of T1D subjects.
###end title 21
###begin p 22
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 564 567 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
Analyses of log10-transformed sIL-2RA concentrations of healthy control, MS and T1D datasets. The analysis of sIL-2RA levels for rs41295061 and rs11594656 in up to 1,257 T1D cases presents a subset of a previously published data set [8]. Analyses were performed using a 2-degree of freedom test. We note that the healthy control and MS case collection present random population samples, but that individuals from the T1D case collection were chosen based on their genotype at both rs41295061 and rs11594656 to achieve representation of all genotypes for both SNPs [8]. This selection allowed the study of the correlation between sIL-2RA levels and the relatively rare minor allele at rs41295061, currently the most strongly associated T1D SNP (MAF = 0.09). N, number of samples.
###end p 22
###begin p 23
###xml 61 63 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 100 109 100 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s014">Table S13</xref>
T1D analyses were adjusted for covariates associated with log10-transformed sIL-2RA concentrations (Table S13).
###end p 23
###begin p 24
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 751 760 751 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s001">Figure S1</xref>
###xml 762 771 762 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000322.s017">Table S16</xref>
###xml 1128 1133 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 1232 1238 1232 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN22</italic>
###xml 1376 1380 1376 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Smyth1">[25]</xref>
###xml 1381 1385 1381 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Criswell1">[27]</xref>
###xml 1474 1478 1474 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Barrett1">[28]</xref>
###xml 1585 1589 1585 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-DeJager1">[29]</xref>
###xml 1590 1594 1590 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Begovich1">[30]</xref>
Our combined genetic analyses of IL2RA variants in MS and T1D result in the discovery of a third, novel group of associated SNPs with T1D (Group III) and identifies a remarkable degree of allelic heterogeneity at this autoimmune susceptibility locus. This demonstrates the presence of (1) a T1D allele not associated with MS (rs41295061 marking Group I), (2) an allele conferring susceptibility to T1D but protection from MS (rs11594656 marking Group II) and (3) an allele shared between T1D and MS (rs2104286 marking Group III). The discovery of allelic heterogeneity between MS and T1D at IL2RA may only be a small window into the complexities that the IL2RA region harbors: GWA studies for both RA and SLE have also observed associations at IL2RA (Figure S1, Table S16); the overlap of associations among these and other diseases should be the focus of future studies. While any of the tested SNPs may be in LD with the true causal variant, the allelic heterogeneity we observe between MS and T1D provides strong evidence for the necessity of performing fine-mapping studies in each disease individually that associates with IL2RA. Another example of such allelic heterogeneity has been observed at the shared autoimmunity locus PTPN22 encoding a lymphotyrosine phosphatase. While T1D, RA and CD all show disease associations that map to the same R620W variant (rs2476601) [25]-[27], it is the 620W variant that associates with risk to T1D and RA, but protection from CD [28]. We note that R620W has not shown association with MS susceptibility in the populations analyzed thus far [29],[30], but studies employing larger sample sizes will need to further address this variant in MS.
###end p 24
###begin p 25
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 668 671 668 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
Our analysis of how disease susceptibility correlates with sIL-2RA levels suggest discordance between sIL-2RA level and disease susceptibility and calls for studies addressing causality of sIL-2RA in autoimmune disease. It is plausible that the three independent genetic associations marked by Group I to III SNPs present independent biological pathways that contribute to disease susceptibility. These pathways may involve transcriptional regulation of IL2RA, levels of surface expression of IL-2RA, in addition to serum sIL-2RA levels. In light of multiple, independent associations present at IL2RA, the genotype/phenotype correlations observed here and previously [8] may require extension to haplotype/phenotype correlations in sample sizes an order of magnitude greater than are currently available. Nevertheless, these data represent a comparative study between MS/T1D susceptibility and production of sIL-2RA and show that multiple variants contribute independently not only to disease susceptibility but also to an individual's sIL-2RA level.
###end p 25
###begin title 26
Materials and Methods
###end title 26
###begin title 27
Subjects
###end title 27
###begin p 28
All case and control subjects were of self-reported white ethnicity and were enrolled under study protocols approved by the Institutional Review Board of each institution that contributed.
###end p 28
###begin p 29
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Hafler1">[31]</xref>
###xml 380 383 380 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
MS and T1D cases: Trio families and MS cases were collected as described in our recent investigation of patients with MS [31]. Subjects with MS all meet McDonald criteria for MS. T1D subjects were recruited as part of the Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory's British case collection (Genetic Resource Investigating Diabetes) [8], which is a joint project between the University of Cambridge Department of Pediatrics and the Department of Medical Genetics at the Cambridge Institute for Medical Research. Most cases were <16 years of age at the time of collection. All were under age 17 years at diagnosis, resided in Great Britain, and were of European descent (self-reported).
###end p 29
###begin p 30
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 783 786 783 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 96 101 <span type="species:ncbi:9606">Women</span>
###xml 663 668 <span type="species:ncbi:9606">Child</span>
Healthy Control Subjects: Healthy adult control subjects were recruited through the Brigham and Women's Hospital and the University of California at San Francisco, as previously described [6]. They consisted of unrelated individuals who were self-reported as being of non-Hispanic white origin and having no history of chronic inflammatory disease. In addition, we included data from 1,679 control individuals collected throughout the USA as part of a GWAS of bipolar disorders sponsored by the NIMH (). The GB control subjects were obtained from two collections, with 5,239 obtained from the British 1958 Birth Cohort, all born during one week in 1958 (National Child Development Study) and the remaining 1,445 controls selected from the UK Blood Services (UKBS) control collection [6]. All GB control subjects were of white ethnicity.
###end p 30
###begin title 31
Genotyping
###end title 31
###begin p 32
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 607 610 607 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-The1">[6]</xref>
###xml 855 858 855 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
SNPs were genotyped using the iPLEX Sequenom MassARRAY platform, TaqMan (Applied Biosystems), or MIP technology (Affymetrix) in accordance with the manufacturer's instructions. We analyzed only SNPs with high quality data (>95% genotype call rate, Hardy-Weinberg equilibrium in controls or unaffected parent P-value>0.001). MS collections were genotyped at the Broad Institute: rs41295061 and rs11594656 were genotyped using iPLEX Sequenom MassARRAY platform. The previously published data for the MS cases and healthy controls from the USA as well as the MS cases from GB were obtained from MIP technology [6]. GB healthy controls and GB T1D case were genotyped for rs2104286 using TaqMan genotyping at the Diabetes and Inflammation Laboratory. The previously published T1D data for rs41295061 and rs11594656 were obtained from TaqMan and MIP technology [8].
###end p 32
###begin title 33
sIL-2RA Measurements
###end title 33
###begin p 34
###xml 366 368 360 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
ELISA measurement of sIL-2RA was performed according to the manufacturer's recommendations (BD Biosciences). Serum samples were diluted 1:20 using PBS supplemented with 10% FBS. Microtiter plates were read using a Biorad Benchmark microplate reader. T1D plasma samples, healthy control and MS subject serum samples were stored at -80degreesC prior to analyses. A log10 transformation of total sIL-2RA concentration was used to provide a Normally distributed outcome. For T1D plasma samples, the analysis was adjusted for independently associated covariates, namely, age, duration of T1D and plasma storage duration. The healthy control subject population consisted of 60.3% females, 29.7% males, with an average age of 43 (range = 20-68) and an average sample storage duration of 2.1 years (range = 1.27-3.15). The MS subject population consisted of 74.2% females, 25.8% males, with an average age of 43 (range = 18-73) and an average sample storage duration of 2.4 (range = 1.1-3.3).
###end p 34
###begin title 35
Statistical Analysis
###end title 35
###begin p 36
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Clayton1">[32]</xref>
###xml 715 716 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 726 728 726 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1021 1025 1021 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Ueda1">[33]</xref>
###xml 1276 1277 1276 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1364 1365 1364 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1365 1366 1365 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1411 1415 1411 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Barrett2">[34]</xref>
###xml 1481 1485 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Chapman1">[35]</xref>
All statistical analyses were performed in either the Stata or R statistical systems. Single locus tests, logistic regression analyses, 2-d.f. locus-based tests were performed as described in [8]. Briefly, logistic regression analyses for the GB case-control collection were adjusted for 12 broad geographical regions within GB to minimize any confounding due to variation in allele frequencies across the country [32]. A multiplicative allelic effects model was assumed as it was not significantly different from the full genotype model for any of the SNPs (except for rs2104286 in the USA case-control collection, for which a full model was chosen as it was significantly different from the multiplicative model; P = 6.57x10-3). SNPs were modeled as a numerical indicator variable coded 0, 1 or 2, representing the number of occurrences of the minor allele. In the forward logistic regression analysis, we start by assessing the evidence against the most significant SNP being alone sufficient to model the association [33]. No specific mode of inheritance for the most associated SNP (A>a) or any additional SNP with significant independent effects of disease susceptibility was assumed, so genotype risks of A/A and A/a were modeled relative to the a/a genotype. Combined P values for the USA and GB case-control were stratified by population. Measures LD, D' r2 were calculated using the Haploview package [34]. Power calculations were performed using the method described in [35].
###end p 36
###begin title 37
Supporting Information
###end title 37
###begin p 38
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2RA</italic>
###xml 243 246 243 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Harley1">[12]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Barton1">[14]</xref>
Comparison of IL2RA variants genotyped in T1D, MS, RA and SLE. Minor allele associations with disease are shown. Odds ratios and 95% confidence intervals of association results are shown from the current study and previously published studies [8],[12],[14].
###end p 38
###begin p 39
(0.11 MB DOC)
###end p 39
###begin p 40
Click here for additional data file.
###end p 40
###begin p 41
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Single-locus test P values for rs2104286, rs11594656 and rs41295061 in 2,115 MS cases and 6,902 healthy controls with complete genotype information (analysis stratified by population). MAF, minor allele frequency. OR, odds ratio.
###end p 41
###begin p 42
(0.03 MB DOC)
###end p 42
###begin p 43
Click here for additional data file.
###end p 43
###begin p 44
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Single-locus test P values for rs2104286, rs11594656 and rs41295061 in 1,183 MS cases and 582 healthy controls from the USA with complete genotype information. MAF, minor allele frequency. OR, odds ratio.
###end p 44
###begin p 45
(0.03 MB DOC)
###end p 45
###begin p 46
Click here for additional data file.
###end p 46
###begin p 47
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Single-locus test P values rs2104286, rs11594656 and rs41295061 in 932 MS cases and 6,320 healthy controls from GB with complete genotype information. MAF, minor allele frequency. OR, odds ratio.
###end p 47
###begin p 48
(0.03 MB DOC)
###end p 48
###begin p 49
Click here for additional data file.
###end p 49
###begin p 50
###xml 141 146 <span type="species:ncbi:9606">child</span>
Power calculations to detect variants with odds ratios ranging from 1.1 to 1.4 and a minor allele frequency (MAF) of 0.10 using 1,250 parent/child trios. MAF, minor allele frequency. OR, odds ratio.
###end p 50
###begin p 51
(0.03 MB DOC)
###end p 51
###begin p 52
Click here for additional data file.
###end p 52
###begin p 53
Power calculations to detect the effect of variants with odds ratios ranging from 1.1 to 1.3 and a minor allele frequency (MAF) of 0.10 using 2,400 MS cases and 9,100 healthy controls. MAF, minor allele frequency. OR, odds ratio.
###end p 53
###begin p 54
(0.03 MB DOC)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
###xml 160 165 <span type="species:ncbi:9606">child</span>
Power calculations to detect the effect of variants with odds ratios (OR) ranging from 1.1 to 1.4 and a minor allele frequency (MAF) of 0.25 using 1,250 parent/child trios.
###end p 56
###begin p 57
(0.03 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 401 405 401 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">diff</sub>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regression analysis (a) adding rs11594656 and rs41295061 to rs2104286 and reverse regression analysis (b) adding rs2104286 to rs11594656 and rs41295061 for 2,115 MS cases and 6,902 controls with complete genotype information (analysis stratified by population). 1 Results for a model assuming multiplicative effects and 2 for a model assuming genotype effects (full model) are shown. OR, odds ratio; Pdiff = P value for tests between multiplicative and full models.
###end p 59
###begin p 60
(0.05 MB DOC)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
LD between rs2104286 and all common variants located between 5.904,506 bp and 6.403,954 bp on chromosome 10. Positions are given using NCBI build 36. rs and in-house (DIL) SNP numbers are shown. LD measures are calculated based on 32 CEPH individuals; genotyping data are obtained from HapMap () and [8].
###end p 62
###begin p 63
(0.12 MB DOC)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 175 176 175 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 314 318 314 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">diff</sub>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regression analysis adding rs2104286 and rs11594656 to rs41295061 and regression analysis adding rs41295061 to rs2104286 and rs11594656 in 6,425 T1D cases and 6,862 controls. 1 Results for a model assuming multiplicative effects and 2 for a model assuming genotype effects (full model) are shown. OR, odds ratio; Pdiff = P value for tests between multiplicative and full models.
###end p 65
###begin p 66
(0.05 MB DOC)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 249 250 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 330 334 330 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">diff</sub>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regression analysis (a) adding rs2104286 to rs41295061 and rs11594656 and reverse regression analysis (b) adding rs41295061 and rs11584656 to rs2104286 in 6,425 T1D cases and 6,862 controls. 1 Results for a model assuming multiplicative effects and 2 for a model assuming genotype effects (full model) are shown. OR, odds ratio; Pdiff = P value for tests between multiplicative and full models.
###end p 68
###begin p 69
(0.06 MB DOC)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Chapman1">[35]</xref>
Power calculations to detect the effect of variants with a minor allele frequency of 0.10 using 70 subjects. Power calculations were performed using the method described in [35].
###end p 71
###begin p 72
(0.04 MB DOC)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Chapman1">[35]</xref>
Power calculations to detect the effect of variants with a minor allele frequency of 0.10 using 280 subjects. Power calculations were performed using the method described in [35].
###end p 74
###begin p 75
(0.04 MB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 250 252 250 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 672 673 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 742 744 742 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Covariates associated with sIL-2RA concentrations in T1D analysis. We adjusted for the covariates year of birth, duration of disease and duration of storage of the plasma sample prior to processing, as these were all independently associated with log10-transformed sIL-2RA concentrations. Covariates were selected using forward and then reverse regression. The following covariates: gender, broad geographical region and the age and month when the plasma sample was collected all had P-values>0.05 when added to the selected covariates. Year of birth, duration of disease and the duration of storage of the plasma sample prior to processing were independently associated (P>0.05) and together account for 10.3% of the total variation with log10-transformed sIL-2RA concentration with the direction and magnitude shown in the table below. *%CV is the variation accountable by each covariate.
###end p 77
###begin p 78
(0.04 MB DOC)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 194 196 194 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 356 360 356 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">diff</sub>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regression analysis adding rs2104286 and rs41295061 to rs11594656 and the reverse regression analysis adding rs11594656 to rs2104286 and rs41295061 in complete data for 1,167 T1D cases using log10-transformed sIL-2RA concentrations. 1 Results for a model assuming multiplicative effects and 2 for a model assuming genotype effects (full model) are shown. Pdiff = P value for tests between multiplicative and full models.
###end p 80
###begin p 81
(0.06 MB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 248 250 248 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Regression analysis (a) adding rs2104286 to rs11594656 and rs41295061 and reverse regression analysis (b) adding rs11594656 to rs2104286 and rs41295061 and adding rs41295061 to rs2104286 and rs11594656 in complete data for 1,167 T1D cases using log10-transformed sIL-2RA concentrations.
###end p 83
###begin p 84
(0.07 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 127 130 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Lowe1">[8]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Harley1">[12]</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000322-Barton1">[14]</xref>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
r2 values for the four SNPs associated with T1D, MS or RA and the four SNPs studied in a GWA study for SLE susceptibility loci [8],[12],[14]. r2 values are based on a maximum of 32 CEPH individuals. Allele frequencies are shown in the top diagonal line.
###end p 86
###begin p 87
(0.05 MB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 274 282 <span type="species:ncbi:9606">Children</span>
We gratefully acknowledge the participation of all the patients and control subjects. We acknowledge use of the DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council and Wellcome Trust. We thank The Avon Longitudinal Study of Parents and Children laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton for preparing and providing the control DNA samples. Thanks to the National Institutes of Mental Health for generously allowing the use of their genotype data.
###end p 89
###begin p 90
The International Multiple Sclerosis Genetics Consortium
###end p 90
###begin p 91
###xml 1092 1097 <span type="species:ncbi:9606">Human</span>
###xml 1201 1206 <span type="species:ncbi:9606">Human</span>
Mark J. Daly, Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA, and Massachusetts General Hospital, Harvard Medical School, Boston; Paul I. W. de Bakker, Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA and Harvard Partners Center for Genetics and Genomics, Boston, MA; Stacey B. Gabriel, Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA; Daniel B. Mirel, Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA; Adrian J. Ivinson, Harvard Center for Neurodegeneration and Repair, Harvard Medical School, Boston, MA Margaret A. Pericak-Vance, Duke University Medical Center, Durham, NC and University of Miami School of Medicine, Miami, FL; Simon G. Gregory, Duke University Medical Center, Durham, NC; John D. Rioux, Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA and Universite de Montreal, Montreal Heart Institute, Montreal, Canada; Jacob L. McCauley, Center for Human Genetics Research, Vanderbilt University Medical Center, Nashville, TN; Jonathan L. Haines, Center for Human Genetics Research, Vanderbilt University Medical Center, Nashville, TN; Lisa F. Barcellos, University of California at Berkeley, Berkeley, CA and University of California at San Francisco, San Francisco, CA.
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
The developing mosaic of autoimmune disease risk.
###end article-title 93
###begin article-title 94
###xml 39 44 <span type="species:ncbi:9606">human</span>
Protein tyrosine phosphatase PTPN22 in human autoimmunity.
###end article-title 94
###begin article-title 95
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.
###end article-title 95
###begin article-title 96
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
###end article-title 96
###begin article-title 97
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.
###end article-title 97
###begin article-title 98
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study.
###end article-title 98
###begin article-title 99
Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
###end article-title 99
###begin article-title 100
Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.
###end article-title 100
###begin article-title 101
Toward further mapping of the association between the IL2RA locus and type 1 diabetes.
###end article-title 101
###begin article-title 102
IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.
###end article-title 102
###begin article-title 103
Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs.
###end article-title 103
###begin article-title 104
###xml 32 37 <span type="species:ncbi:9606">women</span>
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.
###end article-title 104
###begin article-title 105
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 105
###begin article-title 106
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.
###end article-title 106
###begin article-title 107
Refining genetics associations in multiple sclerosis.
###end article-title 107
###begin article-title 108
Tolerance, not immunity, crucially depends on IL-2.
###end article-title 108
###begin article-title 109
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system.
###end article-title 109
###begin article-title 110
Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis.
###end article-title 110
###begin article-title 111
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patients.
###end article-title 111
###begin article-title 112
Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
###end article-title 112
###begin article-title 113
Elevated levels of soluble interleukin-2 receptors in multiple sclerosis.
###end article-title 113
###begin article-title 114
Interleukin-2 receptor levels indicating relapse in multiple sclerosis.
###end article-title 114
###begin article-title 115
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
###end article-title 115
###begin article-title 116
Genomewide study of multiple sclerosis.
###end article-title 116
###begin article-title 117
PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes.
###end article-title 117
###begin article-title 118
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.
###end article-title 118
###begin article-title 119
Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.
###end article-title 119
###begin article-title 120
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
###end article-title 120
###begin article-title 121
Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis.
###end article-title 121
###begin article-title 122
The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis.
###end article-title 122
###begin article-title 123
Risk alleles for multiple sclerosis identified by a genomewide study.
###end article-title 123
###begin article-title 124
Population structure, differential bias and genomic control in a large-scale, case-control association study.
###end article-title 124
###begin article-title 125
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
###end article-title 125
###begin article-title 126
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 126
###begin article-title 127
Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power.
###end article-title 127
###begin p 128
The authors have declared that no competing interests exist.
###end p 128
###begin p 129
This work was funded by the Juvenile Diabetes Research Foundation (JDRF) International, the Wellcome Trust, the National Multiple Sclerosis Society (NMSS), the National Institute for Health Research Cambridge Biomedical Research Centre, and the National Institutes of Health (P01 AI39571). The Cambridge Institute for Medical Research is the recipient of a Wellcome Trust Strategic Award (079895). Further supported by a JDRF Postdoctoral Fellowship (LMM), a grant by the American Cancer Society (DEA), an NIH grant (to The IMSGC, NS049477), a Harry Weaver Neuroscience Scholar award by the NMSS (PLD), and a Jacob Javits Merit Award (NS2427, to DAH) from the National Institute of Neurological Disorders and Stroke. LSW is a Wellcome Trust Principal Research Fellow.
###end p 129

